Sglt Inhibitors Explored As Type 1 Diabetes Treatment | Latest News RSS feed

Sglt Inhibitors Explored As Type 1 Diabetes Treatment - Latest News


Recommendations issued for managing SGLT inhibitor-associated DKA risk in type 1 diabetes

medwireNews: Experts have developed consensus recommendations for minimizing diabetic ketoacidosis (DKA) risk in patients with type 1 diabetes treated with ... an increase in absolute DKA risk with SG... read more

Diabetes Health Podcast News: Is There a Link Between SGLT2 Inhibitors and Urinary Tract Infections?

If you’ve been prescribed a sodium-glucose cotransporter-2 (SGLT2) inhibitor ... diabetes really affected them. Eating candy bars, hiding the candy wrappers and smoking cigarettes seemed innocent enou... read more

Differences Between Type 1 and Type 2 Diabetes

Prediabetes treatment ... can help manage Type 2 diabetes, Graham says. These include metformin, sulfonylureas, meglitinides, DPP-4 inhibitors, GLP-1 receptor agonists, SGLT-2 inhibitors and ... read more

Looking for another news?


Type 2 Diabetes Drugs Linked to Higher Cardiovascular Risk

According to Drugs.com, a GLP-1 agonist drug like dulaglutide (Trulicity) currently retails for more than $700 per month. A SGLT-2 inhibitor ... type 2 diabetes and are taking sulfonylureas or insulin ... read more


3 Top Diabetes Stocks to Watch in February

Although Lexicon does have one approved drug already on the market -- Xermelo, a treatment ... next-generation type 1 and 2 diabetes drug that works at inhibiting SGLT1 and SGLT2. Mind you, there are ... read more

New Data Show Lilly's Trulicity® (dulaglutide) in Combination with an SGLT-2 Inhibitor Improves Blood Sugar Control in People with Type 2 Diabetes

1 These data were published online ... that the combination of once-weekly Trulicity and an SGLT-2 inhibitor shows significant promise in helping more people with type 2 diabetes reach their treatment ... read more

Lexicon Likely Looking At Even More Competition In Type 1 Diabetes

Data from Phase III trials of Lilly/Boehringer's Jardiance in Type 1 diabetes supports submission ... for whom there are minimal treatment options beyond insulin therapy (and off-label SGLT-2 inhibito... read more

SGLT-2 Inhibitors: A New Mechanism for Glycemic Control

Type 2 diabetes is a progressive, chronic metabolic disease characterized by hyperglycemia. 1 Beyond being ... concept of inhibition of SGLT-2 marks a departure in how diabetes is viewed and approache... read more

John Buse 2018 Transcript

Buse: A cure — well, for a type 2 diabetes, bariatric surgery is close for many patients. I think, well, I’m very impressed that these GLP-1 Receptor Agonists and SGLT-2 Inhibitors ... but really good ... read more

Certain SGLT2 inhibitors, GLP-1 RAs for T2DM also cut CV risk

(HealthDay)—Certain sodium-glucose cotransporter 2 (SGLT2) inhibitors and glucagon-like peptide 1 receptor agonists (GLP-1 RAs) demonstrate significant cardiovascular (CV) benefit and should be used f... read more

SGLT2 Inhibitors

The information on this site is not intended or implied to be a substitute for professional medical advice, diagnosis or treatment ... A decade later I married a type 1 person living with diabetes and ... read more

FDA Advisory Committee Votes on Zynquista™ (sotagliflozin) as Treatment for Adults With Type 1 Diabetes

Sotagliflozin is an investigational oral dual SGLT1 and SGLT2 inhibitor under regulatory review as an adjunct to insulin for the treatment of adults with type 1 diabetes (T1D). While the FDA is not re... read more



FeedsRSS Created by. Full RSS Feed | Privacy Policy | Contact Us